Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad Tang

Showing results (81-90 of 221) with videos related to

Pageof 23
Sort By:
Lung Cancer (Amsterdam, Netherlands)|May 23, 2015
Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumorsAadel A Chaudhuri, Chad Tang, Michael S Binkley, et al.
Brachytherapy|November 21, 2025
Assessment of brachytherapy-induced prostate edema on postimplant dosimetric analysis in patients treated with magnetic resonance imaging-assisted radiosurgery (MARS)Kathryn E Marqueen, Kelsey L Corrigan, Surendra Prajapati, et al.
Current Treatment Options in Oncology|January 11, 2024
Surgical Management and Considerations for Patients with Localized High-Risk Prostate CancerAndrew M Fang, Jamaal Jackson, Justin R Gregg, et al.
Current Treatment Options in Oncology|April 20, 2024
Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate CancerAndrew M Fang, Jamaal Jackson, Justin R Gregg, et al.
BJUI Compass|October 17, 2024
MR-Linac-guided stereotactic radiotherapy for CT-indiscernible intravascular renal cell carcinoma tumoursMihir D Shanker, Zhiqian Henry Yu, Jinzhong Yang, et al.
Oral Oncology|April 7, 2015
Prognostic factors in adenocarcinoma of the salivary glandsAndrew T Huang, Chad Tang, Diana Bell, et al.
JAMA Network Open|December 9, 2020
Assessment of Trends in Second Primary Cancers in Patients With Metastatic Melanoma From 2005 to 2016Weiye Deng, Yifan Wang, Xiangyu Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2017
Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled TrialsJennifer K Logan, Chad Tang, Zhongxing Liao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2026
Renal Medullary Carcinoma: Utility of [<sup>18</sup>F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment ManagementSimone Krebs, Ahmed E Salem, Nghi C Nguyen, et al.
Clinical Lung Cancer|April 25, 2018
Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non-Small-Cell Lung Cancer After Definitive Radiation TherapyCharissa R Kim, Bumyang Kim, Matthew S Ning, et al.
Pageof 23

Showing results (81-90 of 221) with videos related to

Sort By:
Pageof 23
Lung Cancer (Amsterdam, Netherlands)|May 23, 2015
Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumorsAadel A Chaudhuri, Chad Tang, Michael S Binkley, et al.
Brachytherapy|November 21, 2025
Assessment of brachytherapy-induced prostate edema on postimplant dosimetric analysis in patients treated with magnetic resonance imaging-assisted radiosurgery (MARS)Kathryn E Marqueen, Kelsey L Corrigan, Surendra Prajapati, et al.
Current Treatment Options in Oncology|January 11, 2024
Surgical Management and Considerations for Patients with Localized High-Risk Prostate CancerAndrew M Fang, Jamaal Jackson, Justin R Gregg, et al.
Current Treatment Options in Oncology|April 20, 2024
Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate CancerAndrew M Fang, Jamaal Jackson, Justin R Gregg, et al.
BJUI Compass|October 17, 2024
MR-Linac-guided stereotactic radiotherapy for CT-indiscernible intravascular renal cell carcinoma tumoursMihir D Shanker, Zhiqian Henry Yu, Jinzhong Yang, et al.
Oral Oncology|April 7, 2015
Prognostic factors in adenocarcinoma of the salivary glandsAndrew T Huang, Chad Tang, Diana Bell, et al.
JAMA Network Open|December 9, 2020
Assessment of Trends in Second Primary Cancers in Patients With Metastatic Melanoma From 2005 to 2016Weiye Deng, Yifan Wang, Xiangyu Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2017
Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled TrialsJennifer K Logan, Chad Tang, Zhongxing Liao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2026
Renal Medullary Carcinoma: Utility of [<sup>18</sup>F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment ManagementSimone Krebs, Ahmed E Salem, Nghi C Nguyen, et al.
Clinical Lung Cancer|April 25, 2018
Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non-Small-Cell Lung Cancer After Definitive Radiation TherapyCharissa R Kim, Bumyang Kim, Matthew S Ning, et al.
Pageof 23